Comment on

• Comparing Non-Vitamin K Oral Anticoagulants: Where We Are Now.

  Parks AL, Redberg RF. Parks AL, et al. JAMA Intern Med. 2016 Nov 1;176(11):1672. doi: 10.1001/jamainternmed.2016.6429. JAMA Intern Med. 2016. PMID: 27695820 No abstract available.
• Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.

  Graham DJ, Reichman ME, Wernecke M, Hsueh YH, Izem R, Southworth MR, Wei Y, Liao J, Goulding MR, Mott K, Chillarige Y, MaCurdy TE, Worrall C, Kelman JA. Graham DJ, et al. JAMA Intern Med. 2016 Nov 1;176(11):1662-1671. doi: 10.1001/jamainternmed.2016.5954. JAMA Intern Med. 2016. PMID: 27695821